CompletedPhase 3NCT00161824

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Studying Encephalitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pfizer
Principal Investigator
Jerzy Romaszko, MD
PANTAMED sp. z o o.
Intervention
Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)(biological)
Enrollment
3800 enrolled
Eligibility
16-65 years · All sexes
Timeline
20012002

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00161824 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis

← Back to all trials